Unexpected BNP levels in patients with advanced heart failure: A tale of caution and promise

American Heart Journal

Volumn 149, Issue 2, 2005, Pages 187-189

  Drazner, Mark H ^a,b   De Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ARTERY CATHETER; CENTRAL VENOUS PRESSURE; CONGESTIVE HEART FAILURE; DYSPNEA; EDITORIAL; HEALTH CARE COST; HEART CATHETERIZATION; HEART INDEX; HEART MUSCLE CELL; HEMODYNAMICS; HUMAN; LUNG CAPILLARY PRESSURE; PRIORITY JOURNAL;

EID: 14844310274     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.06.009     Document Type: Editorial

References (29)

1. J.A. de Lemos, D.K. McGuire, and M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
2. C. Mueller, A. Scholer, and K. Laule-Kilian Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N. Engl. J. Med. 350 2004 647 654
3. K. Maeda, T. Tsutamoto, and A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J. Am. Coll. Cardiol. 36 2000 1587 1593
4. D. Logeart, G. Thabut, and P. Jourdain Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J. Am. Coll. Cardiol. 43 2004 635 641
5. M. Packer Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 108 2003 2950 2953
6. A. Nohria, E. Lewis, and L.W. Stevenson Medical management of advanced heart failure JAMA 287 2002 628 640
7. L.W. Stevenson, K.A. Dracup, and J.H. Tillisch Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation Am. J. Cardiol. 63 1989 461 464
8. M.R. Shah, C.M. O'Connor, and G. Sopko Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE): design and rationale Am. Heart. J. 141 2001 528 535
9. L.W. Stevenson, and J.K. Perloff The limited reliability of physical signs for estimating hemodynamics in chronic heart failure JAMA 261 1989 884 888
10. M.H. Drazner, B. Thompson, and P.B. Rosenberg Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy Am. J. Cardiol. 89 2002 993 995
11. C.V. Leier, J.B. Young, and T.B. Levine Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination Congest. Heart Fail. 7 2001 297 308
12. M.H. Drazner, M.A. Hamilton, and G. Fonarow Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure J. Heart. Lung Transplant 18 1999 1126 1132
13. K. Maeda, T. Tsutamoto, and A. Wada Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am. Heart J. 135 1998 825 832
14. A. Gegenhuber, T. Mueller, and F. Firlinger Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure Clin. Chem. 50 2004 454 456
15. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J. Card Fail. 7 2001 21 29
16. J.O. O'Neill, C.B. Bott-Silverman, and A.T. McRae III B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure Am Heart J. 149 2005 363 369
17. W.H. Tang, J.P. Girod, and M.J. Lee Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure Circulation 108 2003 2964 2966
18. H. Dokainish, W.A. Zoghbi, and N.M. Lakkis Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters Circulation 109 2004 2432 2439
19. M.M. Redfield, R.J. Rodeheffer, and S.J. Jacobsen Plasma brain natriuretic peptide concentration: impact of age and gender J. Am. Coll. Cardiol. 40 2002 976 982
20. T.J. Wang, M.G. Larson, and D. Levy Impact of age and sex on plasma natriuretic peptide levels in healthy adults Am. J. Cardiol. 90 2002 254 258
21. T.J. Wang, M.G. Larson, and D. Levy Impact of obesity on plasma natriuretic peptide levels Circulation 109 2004 594 600
22. A.H. Wu, and A. Smith Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure Eur. J. Heart Fail. 6 2004 355 358
23. A.H. Wu, A. Smith, and S. Wieczorek Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am. J. Cardiol. 92 2003 628 631
24. R.W. Troughton, D.L. Prior, and J.J. Pereira Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function J. Am. Coll. Cardiol. 43 2004 416 422
25. Y. Mizuno, M. Yoshimura, and E. Harada Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy Am. J. Cardiol. 86 2000 1036 1040 [A11]
26. Mayer SA, De Lemos JA, Murphy SA, et al. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus wihout mitral regurgitation. Am J Cardiol 2004;93:1002-6.
27. L.B. Rosario, L.W. Stevenson, and S.D. Solomon The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size J. Am. Coll. Cardiol. 32 1998 1819 1824
28. M.G. Andreassi, S. Del Ry, and C. Palmieri Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones Eur. J. Heart Fail. 3 2001 407 414
29. T.J. Wang, M.G. Larson, and D. Levy Heritability and genetic linkage of plasma natriuretic peptide levels Circulation 108 2003 13 16